Csenge Advisory Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-936
Closed -$204K 722
2024
Q1
$204K Sell
936
-555
-37% -$122K 0.01% 671
2023
Q4
$339K Buy
1,491
+41
+3% +$8.61K 0.02% 496
2023
Q3
$292K Sell
1,450
-828
-36% -$175K 0.02% 495
2023
Q2
$472K Sell
2,278
-29
-1% -$5.63K 0.03% 389
2023
Q1
$455K Buy
2,307
+672
+41% +$138K 0.03% 374
2022
Q4
$331K Sell
1,635
-549
-25% -$107K 0.03% 442
2022
Q3
$384K Sell
2,184
-263
-11% -$53.8K 0.03% 398
2022
Q2
$493K Sell
2,447
-185
-7% -$39.4K 0.04% 342
2022
Q1
$596K Buy
+2,632
New +$619K 0.05% 342
2021
Q4
Sell
-1,651
Closed -$396K 591
2021
Q3
$396K Buy
+1,651
New +$416K 0.03% 415
2018
Q4
Sell
-51
Closed -$7K 886
2018
Q3
$7K Buy
+51
New +$7.76K ﹤0.01% 561

Other funds holding LH

Csenge Advisory Group's LH Position: Q2 2024 in Review

Csenge Advisory Group sold out of Labcorp (LH) in Q2 2024, closing a stake of 936 shares — an estimated $204K sold.

Csenge Advisory Group first reported a position in LH in Q3 2018 and held it in 11 quarters. The position peaked at $596K in Q1 2022. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Csenge Advisory Group reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Csenge Advisory Group sold 936 Labcorp shares in Q2 2024, an estimated $204K.
  • Csenge Advisory Group first reported a position in Labcorp in Q3 2018 and held it in 11 quarters.
  • Csenge Advisory Group's Labcorp position peaked at $596K in Q1 2022.
  • 854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Csenge Advisory Group's 13F filing for Q2 2024, filed 10 Jul 2024.